Mark Lythgoe: Improving outcomes in cervix cancer – 10 years in the making and no expensive drugs

Mark Lythgoe, Academic Clinical Fellow in Medical Oncology and Pharmacist at Imperial College London, shared on X:

“Important Science and Innovation at Cancer Research UK, UCL led study improving outcomes in cervix cancer – 10yrs in the making and no expensive drugs.

Significants implications for standard of care globally in high and low income countries.”